13th International Symposium of Targeted Alpha Therapy (TAT 13)

TAT 13 will cover recent updates, innovations, and advances in preclinical studies, clinical practices, translational applications, dosimetry, instrumentation, quality assurance, regulatory, targeting, radiochemistry, and nuclide production, supply, and logistics.

TAT 13 will be held in Rio de Janeiro, BRAZIL, from April 14 to 16, 2026, at the Windsor Barra Convention Center. TAT 13 will be organized by the Brazilian Society of Nuclear Medicine and Molecular Imaging, along with the Joint Research Centre of the European Commission.